Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.21.1
Segment Information (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
USD ($)
segment
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Segment information      
Number of business segments | segment 4    
Net sales:      
Total net sales revenue $ 102,421 $ 95,926  
Contribution margin:      
Total contribution margin 41,187 38,227  
Selling, general and administrative expenses 33,552 31,065  
Operating income 7,635 7,162  
Other loss, net (1,933) (2,410)  
Income before provision for income taxes 5,702 4,752  
Total property, plant and equipment, net 52,552   $ 54,355
Total assets 245,831   249,498
Asia      
Net sales:      
Total net sales revenue 35,755 30,958  
Contribution margin:      
Total contribution margin 15,319 14,527  
Total assets 84,668   82,572
Asia | General health      
Net sales:      
Total net sales revenue 11,292 9,046  
Asia | Immune      
Net sales:      
Total net sales revenue 203 201  
Asia | Cardiovascular      
Net sales:      
Total net sales revenue 9,903 9,339  
Asia | Digestive      
Net sales:      
Total net sales revenue 6,871 6,156  
Asia | Personal care      
Net sales:      
Total net sales revenue 2,524 3,005  
Asia | Weight management      
Net sales:      
Total net sales revenue 4,962 3,211  
Europe      
Net sales:      
Total net sales revenue 22,200 20,627  
Contribution margin:      
Total contribution margin 6,796 6,831  
Total assets 16,533   16,398
Europe | General health      
Net sales:      
Total net sales revenue 9,472 7,961  
Europe | Immune      
Net sales:      
Total net sales revenue 2,016 2,444  
Europe | Cardiovascular      
Net sales:      
Total net sales revenue 2,992 2,897  
Europe | Digestive      
Net sales:      
Total net sales revenue 5,540 4,931  
Europe | Personal care      
Net sales:      
Total net sales revenue 1,426 1,751  
Europe | Weight management      
Net sales:      
Total net sales revenue 754 643  
North America      
Net sales:      
Total net sales revenue 37,762 38,757  
Contribution margin:      
Total contribution margin 15,440 14,419  
Total assets 135,710   142,324
North America | General health      
Net sales:      
Total net sales revenue 16,270 15,464  
North America | Immune      
Net sales:      
Total net sales revenue 4,874 7,798  
North America | Cardiovascular      
Net sales:      
Total net sales revenue 4,225 4,167  
North America | Digestive      
Net sales:      
Total net sales revenue 9,463 8,241  
North America | Personal care      
Net sales:      
Total net sales revenue 1,819 1,929  
North America | Weight management      
Net sales:      
Total net sales revenue 1,111 1,158  
Latin America and Other      
Net sales:      
Total net sales revenue 6,704 5,584  
Contribution margin:      
Total contribution margin 3,632 2,450  
Total assets 8,920   8,204
Latin America and Other | General health      
Net sales:      
Total net sales revenue 1,976 1,614  
Latin America and Other | Immune      
Net sales:      
Total net sales revenue 811 809  
Latin America and Other | Cardiovascular      
Net sales:      
Total net sales revenue 478 378  
Latin America and Other | Digestive      
Net sales:      
Total net sales revenue 2,870 2,362  
Latin America and Other | Personal care      
Net sales:      
Total net sales revenue 345 252  
Latin America and Other | Weight management      
Net sales:      
Total net sales revenue 224 169  
CHINA      
Contribution margin:      
Selling, general and administrative expenses 2,800 1,900  
United States      
Net sales:      
Total net sales revenue 34,920 35,839  
Contribution margin:      
Total property, plant and equipment, net 48,693   50,025
South Korea      
Net sales:      
Total net sales revenue 14,809 16,389  
Other      
Net sales:      
Total net sales revenue 52,692 $ 43,698  
Other      
Contribution margin:      
Total property, plant and equipment, net $ 3,859   $ 4,330